We’re honored to have been named a finalist in the 2018 MM&M Awards in the “Best use of Data/Analytics” category. Our entry, “Boehringer Ingelheim and Aptus Health for Spiriva Respimat: Synchronized HCP and Consumer Campaign at the Point of Care and Beyond” has been recognized by a panel of industry judges as a great example of how data & analytics were used to make effective business decisions and demonstrate value for the brand. It is one of 5 finalists in the category; winners are announced at a gala in October.
This is validation of the great partnership we’ve built with Boehringer Ingelheim; our approach to campaign design and delivery that relies on in-house expertise; and of course the value we deliver to our clients. These awards are well-respected and coveted among pharma marketers.
The Best Use of Data/Analytics category recognizes the “use of new health and non-health data sets and innovative analytics methodologies to identify and target qualified audiences more effectively; validate the impact of exposure to marketing and media (e.g., exposure to multichannel campaigns); and drive media planning and marketing budget allocation decisions beyond the use of traditional approaches.” It is part of the Healthcare Marketing Awards that recognize “outstanding marketing and communications efforts in support of drugs, devices, diagnostics, services, and corporations.”
Read more about the multi-audience campaign we developed with Boehringer Ingelheim for Spiriva Respimat here.
Congratulations to all the finalists!